XML 40 R29.htm IDEA: XBRL DOCUMENT v3.25.3

Business Segments (Tables)

9 Months Ended

Sep. 30, 2025

Segment Reporting [Abstract]

Schedule of Information on Company's Business Segments

The Company uses Adjusted EBITDA as its measure of segment performance. Intersegment sales are contracted with terms equivalent to those of an arm’s-length transaction. Information on the Company’s business segments is presented below.

			Three Months Ended September 30, 2025
			HST						FMT						FSDP						Total Segments						Eliminations						IDEX
NET SALES
External customers			$	380.1					$	316.8					$	181.8					$	878.7					$	—					$	878.7
Intersegment sales			0.9						0.3						0.1						1.3						(1.3)						—
Net sales			381.0						317.1						181.9						880.0						(1.3)						878.7
Adjusted segment cost of sales(1)			(223.3)						(161.8)						(103.7)						(488.8)						1.3						(487.5)
Other segment expenses(2)			(52.3)						(48.5)						(28.9)						(129.7)
Segment Adjusted EBITDA			$	105.4					$	106.8					$	49.3					$	261.5

			Three Months Ended September 30, 2024
			HST						FMT						FSDP						Total Segments						Eliminations						IDEX
NET SALES
External customers			$	309.9					$	300.6					$	187.7					$	798.2					$	—					$	798.2
Intersegment sales			1.1						0.2						0.3						1.6						(1.6)						—
Net sales			311.0						300.8						188.0						799.8						(1.6)						798.2
Adjusted segment cost of sales(1)			(184.1)						(155.4)						(104.3)						(443.8)						1.6						(442.2)
Other segment expenses(2)			(44.3)						(46.9)						(29.0)						(120.2)
Segment Adjusted EBITDA			$	82.6					$	98.5					$	54.7					$	235.8

			Nine Months Ended September 30, 2025
			HST						FMT						FSDP						Total Segments						Eliminations						IDEX
NET SALES
External customers			$	1,084.1					$	917.5					$	556.8					$	2,558.4					$	—					$	2,558.4
Intersegment sales			3.7						1.0						0.9						5.6						(5.6)						—
Net sales			1,087.8						918.5						557.7						2,564.0						(5.6)						2,558.4
Adjusted segment cost of sales(1)			(641.5)						(461.1)						(309.1)						(1,411.7)						5.6						(1,406.1)
Other segment expenses(2)			(158.5)						(146.6)						(88.7)						(393.8)
Segment Adjusted EBITDA			$	287.8					$	310.8					$	159.9					$	758.5

			Nine Months Ended September 30, 2024
			HST						FMT						FSDP						Total Segments						Eliminations						IDEX
NET SALES
External customers			$	922.3					$	933.0					$	550.6					$	2,405.9					$	—					$	2,405.9
Intersegment sales			2.6						0.9						0.8						4.3						(4.3)						—
Net sales			924.9						933.9						551.4						2,410.2						(4.3)						2,405.9
Adjusted segment cost of sales(1)			(546.0)						(478.7)						(302.8)						(1,327.5)						4.3						(1,323.2)
Other segment expenses(2)			(130.7)						(143.6)						(88.7)						(363.0)
Segment Adjusted EBITDA			$	248.2					$	311.6					$	159.9					$	719.7

(1) Adjusted segment cost of sales represents Cost of sales excluding fair value inventory step-up charges. There were step-up charges of $0.6 million during the three and nine months ended September 30, 2025 and $2.1 million and $4.6 million during the three and nine months ended September 30, 2024, respectively. All step-up charges were recorded within the HST segment.

(2) Other segment expenses consists primarily of selling, general and administrative expenses.

			Three Months Ended September 30,												Nine Months Ended September 30,
			2025						2024						2025						2024
ADJUSTED EBITDA
Health & Science Technologies			$	105.4					$	82.6					$	287.8					$	248.2
Fluid & Metering Technologies			106.8						98.5						310.8						311.6
Fire & Safety/Diversified Products			49.3						54.7						159.9						159.9
Segment Adjusted EBITDA			261.5						235.8						758.5						719.7
Corporate and other(1)			(21.7)						(21.5)						(73.5)						(72.9)
Interest expense – net			(16.5)						(10.3)						(48.2)						(27.8)
Depreciation(2)			(19.1)						(17.4)						(56.5)						(49.9)
Amortization of intangible assets(2)			(33.0)						(26.5)						(96.5)						(75.0)
Fair value inventory step-up charges			(0.6)						(2.1)						(0.6)						(4.6)
Restructuring expenses and asset impairments			(0.1)						(3.0)						(18.3)						(5.4)
Gain on sale of business			—						(0.6)						—						4.0
Income before income taxes			$	170.5					$	154.4					$	464.9					$	488.1

(1) Corporate expenses that can be identified with a segment have been included in determining segment results. The remainder are included in Corporate and other.

(2) Depreciation and amortization of intangible assets by segment for the three and nine months ended September 30, 2025 and 2024 was:

			Three Months Ended September 30,												Nine Months Ended September 30,
			2025						2024						2025						2024
DEPRECIATION
Health & Science Technologies			$	11.9					$	10.6					$	35.5					$	29.5
Fluid & Metering Technologies			4.7						4.3						13.5						12.9
Fire & Safety/Diversified Products			2.3						2.2						6.9						6.7
Total Segments			18.9						17.1						55.9						49.1
Corporate and other			0.2						0.3						0.6						0.8
Total depreciation			$	19.1					$	17.4					$	56.5					$	49.9
AMORTIZATION OF INTANGIBLE ASSETS
Health & Science Technologies			$	26.2					$	19.7					$	76.2					$	54.6
Fluid & Metering Technologies			5.5						5.2						16.2						15.7
Fire & Safety/Diversified Products			1.3						1.6						4.1						4.7
Total amortization			$	33.0					$	26.5					$	96.5					$	75.0

			September 30, 2025						December 31, 2024
ASSETS
Health & Science Technologies			$	4,349.6					$	4,142.6
Fluid & Metering Technologies			1,678.2						1,609.4
Fire & Safety/Diversified Products			822.5						794.1
Total Segments			6,850.3						6,546.1
Corporate and other			119.4						199.2
Total assets			$	6,969.7					$	6,745.3

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration